CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

Nuvation Bio (NUVB) has decided to halt the development of NUV-1511, the initial compound in its innovative drug-drug conjugate program. Although NUV-1511, under investigation for solid tumors, was ...

OKLAHOMA CITY, Oct. 29, 2025 /PRNewswire/ -- Wheeler Bio, a U.S.-based High Science/High Touch contract development and biomanufacturing organization (CDMO), today announced a strategic partnership ...

The FDA's draft guidance could streamline biosimilar approval by reducing the need for comparative efficacy studies, emphasizing analytical assessments instead. This approach may lower development ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

The oPool + display platform combines technologies to make and test large numbers of antibodies at once. Antibodies are the critical targeting agents of the immune system and the crux of immune ...

The Design-Build model is an increasingly attractive project delivery method, offering benefits such as enhanced control, reduced risks, cost efficiencies, and quicker completion times. Central to ...

Dave is a veteran game newswriter and has reported for a variety of outlets for over a decade, writing news, reviews, guides and more for online game sites wherever he can find them. A new BioShock 4 ...

The United States led global production of rare earth elements (REEs) until the mid-1990s, when China emerged as the dominant supplier. China maintained near-total control of the market until 2012.